Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | DAO | P14920 | 2/20 | 0.43 |
| ▸ | AURKA | O14965 | 1/20 | 0.43 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.43 |
| ▸ | INCENP | Q9NQS7 | 1/20 | 0.43 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.39 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | PARP1 | P09874 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10692239 | 0.88 | DAO (0.41) | KDM4EGAAMEN1POLBMAPT | |
| SCHEMBL2495417 | 0.86 | GPR84 (0.46) | KDM4EGAATHRBDAOAURKA | |
| SCHEMBL27397512 | 0.85 | GPR84 (0.49) | KDM4ETHRBMCL1ALDH1A1GPR84 | |
| SCHEMBL10767574 | 0.85 | GPR84 (0.49) | KDM4ETHRBMCL1ALDH1A1GPR84 | |
| SCHEMBL14974903 | 0.85 | GPR84 (0.49) | KDM4ETHRBMCL1ALDH1A1GPR84 | |
| SCHEMBL28243243 | 0.85 | GPR84 (0.49) | KDM4ETHRBMCL1ALDH1A1GPR84 | |
| SCHEMBL10764266 | 0.85 | GPR84 (0.49) | KDM4ETHRBMCL1ALDH1A1GPR84 | |
| SCHEMBL5166986 | 0.85 | GPR84 (0.49) | KDM4ETHRBMCL1ALDH1A1GPR84 | |
| SCHEMBL797191 | 0.85 | — | — | |
| SCHEMBL9234355 | 0.81 | DAO (0.45) | KDM4EGAAMEN1POLBMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0093498-B1 | PHARMACEUTICAL COMPOSITIONS CONTAINING N-SUBSTITUTED-3-HYDROXYPYRID-2-ONE OR -4-ONE DERIVATIVES | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1986-11-26 | — | — | EP | claimed |
| EP-4248972-A2 | PYRIDAZINONE COMPOUNDS AND USES THEREOF | EDGEWISE THERAPEUTICS, INC. (US) | 2023-09-27 | — | — | EP | disclosed |
| CN-111542557-B | Conjugated diene rubber | 日本瑞翁株式会社 | 2023-03-28 | — | — | CN | disclosed |
| CN-111868098-B | Method for producing conjugated diene rubber | 日本瑞翁株式会社 | 2022-12-23 | — | — | CN | disclosed |
| CN-115348975-A | Conjugated diene polymer, method for producing conjugated diene polymer, conjugated diene polymer composition, and rubber composition | 旭化成株式会社 | 2022-11-15 | — | — | CN | disclosed |
| CN-114933676-A | Polyfunctional vinyl aromatic copolymer and process for producing the same, conjugated diene copolymer and composition thereof, crosslinked product, and tire member | 日铁化学材料株式会社 | 2022-08-23 | — | — | CN | disclosed |
| CN-110325556-B | Modified conjugated diene polymer, polymer composition, and rubber composition | 旭化成株式会社 | 2022-05-13 | — | — | CN | disclosed |
| CN-110857344-B | Modified conjugated diene polymer composition, rubber composition, and method for producing rubber composition | 旭化成株式会社 | 2022-04-15 | — | — | CN | disclosed |
| CN-110862590-B | Modified conjugated diene polymer composition, rubber composition, and method for producing rubber composition | 旭化成株式会社 | 2022-04-12 | — | — | CN | disclosed |
| CN-110878151-B | Rubber composition | 旭化成株式会社 | 2022-04-12 | — | — | CN | disclosed |
| WO-2012028676-A1 | NEW COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2012-03-08 | — | — | WO | disclosed |
| EP-2167499-B1 | SUBSTITUTED OXAZOLIDINONES AND USE THEREOF | Bayer Pharma AG (DE) | 2011-12-14 | — | — | EP | disclosed |
| EP-2167499-B1 | SUBSTITUTED OXAZOLIDINONES AND USE THEREOF | Bayer Pharma AG (DE) | 2011-12-14 | — | — | EP | disclosed |
| US-20100298293-A1 | SUBSTITUTED OXAZOLIDINONES AND THEIR USE | BAYER SCHERING PHARMA ATIENGESELLSCHAFT (DE) | 2010-11-25 | — | — | US | disclosed |
| US-20100298293-A1 | SUBSTITUTED OXAZOLIDINONES AND THEIR USE | BAYER SCHERING PHARMA ATIENGESELLSCHAFT (DE) | 2010-11-25 | — | — | US | disclosed |
| US-20100298293-A1 | SUBSTITUTED OXAZOLIDINONES AND THEIR USE | BAYER SCHERING PHARMA ATIENGESELLSCHAFT (DE) | 2010-11-25 | — | — | US | disclosed |
| EP-2167499-A2 | SUBSTITUTED OXAZOLIDINONES AND USE THEREOF | Bayer Schering Pharma AG (DE) | 2010-03-31 | — | — | EP | disclosed |
| WO-2008155069-A2 | SUBSTITUTED OXAZOLIDINONES AND USE THEREOF | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2008-12-24 | — | — | WO | disclosed |
| WO-2008155069-A2 | SUBSTITUTED OXAZOLIDINONES AND USE THEREOF | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2008-12-24 | — | — | WO | disclosed |
| EP-0375133-A1 | Alpha-amino-indole-3-acetic acids useful as anti-diabetic, anti-obesity and anti-atherosclerotic agents | THE UPJOHN COMPANY (US) | 1990-06-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100298293-A1 | SUBSTITUTED OXAZOLIDINONES AND THEIR USE | XDH, OXA1L, PPOX | KDM4E 2573/4885GAA 833/4885MEN1 1934/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.